BARCELONA, Spain – Sunday 31 August: An investigational lipid-lowering agent called alirocumab produced superior results compared to placebo in Hot Line studies reported today at ESC Congress 2014.
Fuente : http://www.alphagalileo.org/ViewItem.aspx?ItemId=1...
Fuente : http://www.alphagalileo.org/ViewItem.aspx?ItemId=1...